Read + Share
. Garcia E, Horowitz AM, Franklin K, Mader M, Kaur S. Outcomes of veterans with
FMS-like tyrosine kinase 3 mutated (mFLT3) acute myeloid leukemia (AML) treated
with novel FLT3 inhibitors (FLT3i) within the Veterans Health Administration
(VHA) [abstract] Blood 2024;143:2676.
PMID: 38900483
|
 |
|
